Biopharmaceutical, Medical Device Commercial Executive

Daniel T. Brown

*** ***** **** ****** *** Wheeler Court

Norwell, MA USA 02061 Rockwood, ON, Canada

617-***-**** *********@*****.*** 519-***-****

Summary

Dynamic general management executive with a strong legacy of successful

global business development. Characterized as a team builder who delivers

commercial results through establishing and leading performance cultures

that are customer focused. Global leadership experience and networks at

both the country affiliate and the business unit level, drawing upon more

than 20 years of healthcare experience across biotechnology,

pharmaceuticals, and medical devices. Canadian citizen with dual Canada/USA

residence status, open to global relocation for the right opportunity.

Leadership - Successfully built and developed the Sanofi Global Biosurgery

Liaison Team responsible for globally commercializing the acquired Genzyme

Biosurgery portfolio of products into international affiliates.

Strategically re-built the Genzyme Australasia Senior Management Team of

eight and scaled the organization from 28 to 62 employees, resulting in the

doubling of revenues in excess of $60 million in just over three years.

Over four years, established and developed Genzyme Canada's transplant,

endocrine, and biosurgery commercial teams into a $15 million business.

Commercial Business Development - Engineered the successful global

integration of the Genzyme Biosurgery portfolio of products, producing

revenues in excess of E130 million. Led successful commercial launches of

six new products in the Australian market across multiple product platforms

- biotechnology (orphan/rare disease), pharmaceutical, and medical device.

Profitably re-launched three maturing products in the Canadian market

resulting in double-digit revenue growth.

Building High-Performance Cultures - Consistently demonstrated ability to

drive double-digit revenue growth in both new launch and re-launch

environments. Commercially savvy, building sustainable sales and marketing

teams across diverse product portfolios of orphan/rare disease,

pharmaceutical, and medical device. Repeated success in multiple countries

at developing commercially driven cross-functional senior management teams.

International Business Acumen - Repeated success driving successful

commercial scale-ups in many diverse cultures including China, India,

Japan, Brazil, France, Italy, Canada, and establishing significant product

position in these key markets. Consistent results planning and implementing

commercial metrics and training requirements across varying cultures and

commercial markets.

Experience

Daniel Brown Consulting, Rockwood, Canada 2013 - Present

Daniel Brown Consulting is a global commercialization consulting firm

focused on the biotechnology and specialty medical device industries.

Principle

. Providing strategic planning guidance to start-up companies and private

equity firms looking to launch or scale up in both established and

emerging global markets.

. Market(s) assessment and the development of business models, channel

maps, and commercial infrastructure plans necessary for successful

country/regional commercial launches.

Sanofi, Paris, France 2011 - 2013

A globally integrated French multi-national healthcare company with annual

revenues exceeding E34 billion across a diverse medicines portfolio of

therapeutic solutions and vaccines. +110,000 employees present in more than

100 countries engaged in research, development, manufacturing, and

marketing.

Vice-President and Global Biosurgery Liaison, Cambridge, MA (2011 - 2013)

. Global commercial lead for the Biosurgery Business Unit, generating

annual revenues in excess of E130 million.

. Achieved prioritization and significantly established lead product

positioning in key strategic global markets, both established and

emerging, resulting in double-digit revenue growth.

. Provided commercial leadership and coordinated the development of

innovative business models, staffing profiles, commercial metrics, and

training requirements to support commercialization of the Sanofi

Biosurgery portfolio across all markets.

. Delivered strategic and tactical implementation recommendations as the

global commercial lead to the Sanofi Biosurgery Business Development

and Strategic Planning Team, as well as the Surgical, Orthopaedic and

Arthritis, Business Development Working Groups.

Genzyme Corporation, Cambridge, MA (Acquired by Sanofi in 2011) 2001 -

2011

A globally integrated biotechnology company within the Sanofi Group with

annual revenues exceeding $4 billion focused in the orphan/rare disease

market segments. Originally a US multi-national biotech company, now with

+10,000 employees present in more than 40 countries engaged in research,

development, manufacturing, and marketing.

Vice-President Biosurgery International, Cambridge, MA (2010 - 2011)

. Commercial lead for the Biosurgery Business Unit for the Asia-Pacific,

Latin American, and Canadian Biosurgery businesses, generating annual

revenues in excess of US$120 million.

. Achieved product portfolio prioritization and significantly

established lead product positioning in key strategic global markets,

both established and emerging, resulting in double-digit revenue

growth.

. Assumed commercial leadership and coordinated the development of

innovative business models, commercial metrics, and training

requirements to support commercialization and scale-up of the Genzyme

Biosurgery portfolio in key strategic markets.

. Delivered direction and guidance in the development of both the

strategic plan and product launch plans for key emerging markets:

India, China, Brazil.

. Provided global commercial input as global commercial lead in the

Sanofi integration of Genzyme Biosurgery.

Managing Director, Genzyme Australasia Pty Ltd, Sydney, NSW, Australia

(2006 - 2010)

. Internally recruited and transferred to the General Management role

for the Australia and New Zealand affiliate, doubling revenues

profitably in excess of $60 million in just over three years.

. Full P&L responsibility and broad general management scope

encompassing commercial, finance, market access/government relations,

regulatory affairs, clinical, operations, and human resources.

. Built local capacity and company image by recruiting and developing a

high potential senior management team of eight, expanding the number

of local employees from 28 to 62, and establishing new company

offices.

. Drove double-digit revenue growth through the commercialization of six

new products, diversified across the biotechnology, pharmaceutical,

and medical device segments.

. Served on Senator the Hon. Kim Carr's Pharmaceutical Industry Strategy

Group, tasked with developing a 20-year blueprint for the Australian

Pharmaceutical Industry.

Commercial Director, Biosurgery, Transplant, Endocrine and Oncology (2005 -

2006)

Genzyme Canada Inc., Mississauga, Ontario

. Promoted to assume commercial leadership, direction, and management of

the endocrine and oncology (pharmaceutical) business units in addition

to the transplant (pharmaceutical), and the biosurgery (medical

device) business units, generating combined revenues in excess of $15

million for the Canadian affiliate.

. Drove double-digit revenue growth through the successful restructuring

of the commercial organization into two business units with 16

employees and two key new strategic marketing hires.

. Successfully led the commercial integration of the endocrine business

from a partnered to a direct business model, maintaining a positive

revenue growth trajectory through reorganization.

. Led the development of the oncology pre-launch strategy encompassing

alternative funding assessment resulting in early patient special

access to treatment.

Director, Biosurgery Canada and Transplant Sales, Genzyme Canada Inc.,

Mississauga, Ontario (2003 - 2005)

. Promoted to assume commercial leadership, direction, and management of

the transplant (pharmaceutical) business unit in addition to the

biosurgery (medical device) business unit, generating combined

revenues in excess of $12 million for the Canadian affiliate.

. Drove double-digit revenue growth through the successful commercial

integration of the acquired Sangstat transplant business and sustained

growth of the biosurgery business.

. Engineered the re-launch of Sangstat's lead transplant product and

achieved market segment leadership in the Canadian market in the

second year.

Director, Biosurgery Canada, Genzyme Canada Inc., Mississauga, Ontario

(2001 - 2003)

. Recruited from outside to establish and build biosurgery (medical

device) business unit for Genzyme in Canada.

. Built the Canadian business, driving revenue growth from $4 to more

than $7 million over two years.

. Successfully led the Canadian commercial integration of the acquired

Biomatrix viscosupplement business, as well as restructuring the sales

and marketing organization.

. Accelerated surgical growth by strategically partnering one product,

while effectively managing a recall directly in the same market

segment.

. Provided strategic and tactical recommendations to the global team

tasked with protecting global revenues and margins in the context of

cross-border parallel trade.

C.R. Bard Inc., Murray Hill, NJ 1991 - 2000

A leading US multi-national developer, manufacturer, and marketer of

innovative medical technologies with annual revenues exceeding $3 billion

across a diverse medical device portfolio serving multiple product fields.

+12,000 employees present in more than 90 countries engaged in research,

development, manufacturing, and marketing of over 8,000 products.

Director of Canadian Sales, Mississauga, Ontario (1997 - 2000)

. Promoted to sales leadership of the $28 million Canadian medical

device affiliate's sales and contract teams.

. Developed a performance culture, that over three years, led to revenue

growth trajectory of 8, 11, and 21 percent.

. Designed and built two specialty medical device sales teams,

urology/general surgery/gastroenterology and

radiology/oncology/vascular, managed by a consolidated regional sales

management structure.

. Provided strategic and tactical inputs as a member of the Canadian

affiliate senior management committee.

National Sales Manager, Regional Sales Manager, Territory Manager (1991-

1996)

Baxter Corporation, Canada 1986 - 1991

Product Manager, Territory Manager

American Hospital Supply, Canada 1985 - 1986

Sales Specialist

Education

Ivey Business School, University of Western Ontario, London, ON Canada

MBA Candidate 2015

University of Melbourne Business School, Melbourne, NSW Australia 2007

Leadership Development Program, LDP -Centre for Creative Leadership

Mt Eliza Executive Education

Ivey Business School, University of Western Ontario, London, ON Canada

1999

Ivey Executive Program

Sir Sandford Fleming College, Peterborough, ON Canada 1984

Business Administration Diploma

Canadian Armed Forces, Chilliwack, British Columbia

Graduate, Officer Training Program 1981

Professional Affiliations

MEDEC, Toronto, ON, Canada 2011 - Present

Biotec Canada, Ottawa, ON, Canada 2011 - Present

Ausbiotech, Malvern, VIC, Australia 2006 - 2010

Medicines Australia, Deakin, ACT, Australia 2006 - 2010

Medical Technology Association of Australia, North Sydney, NSW, Australia

2006 - 2010

Pharmaceutical Industry Strategy Group 2008

Senator the Hon. Kim Carr, Minister for Innovation, Industry, Science and

Research

Commonwealth of Australia

Contact this candidate